Schuth Alexander O.
SEC insider (Form 3/4/5 filer). CIK 0001724311. COFO and Secretary at Denali Therapeutics Inc. (DNLI). 14 reported Form 4/5 transactions since Sep 2024; latest on Sep 1, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Schuth Alexander O. has filed insider reports for
- Denali Therapeutics Inc. (DNLI): Officer, COFO and Secretary
Schuth Alexander O.
CIK: 0001724311
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Denali Therapeutics Inc.
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Sep 1, 2026DNLI
Denali Therapeutics Inc.
SaleDirect2.8K shares at avg. $23.44$65K - Aug 11, 2026DNLI
Denali Therapeutics Inc.
SaleDirect2.9K shares at avg. $25.07$72K - Jan 6, 2026DNLI
Denali Therapeutics Inc.
SaleDirect17.2K shares at avg. $16.50$284K - Jan 3, 2026DNLI
Denali Therapeutics Inc.
AwardDirect57.7K shares- - Aug 12, 2025DNLI
Denali Therapeutics Inc.
SaleDirect2.9K shares at avg. $13.58$40K - Jan 7, 2025DNLI
Denali Therapeutics Inc.
SaleDirect2.9K shares at avg. $20.81$60K - Jan 6, 2025DNLI
Denali Therapeutics Inc.
SaleDirect12.3K shares at avg. $20.22$248K - Jan 3, 2025DNLI
Denali Therapeutics Inc.
AwardDirect54.2K shares- - Dec 27, 2024DNLI
Denali Therapeutics Inc.
ExerciseDirect6.7K shares at avg. $5.28$35K - Nov 22, 2024DNLI
Denali Therapeutics Inc.
ExerciseDirect20.5K shares at avg. $0.68$14K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 1, 2026 | DNLI Denali Therapeutics Inc. | Sale | 2,768 | $23.44 | $64,882 | Direct |
| Aug 11, 2026 | DNLI Denali Therapeutics Inc. | Sale | 2,857 | $25.07 | $71,625 | Direct |
| Jan 6, 2026 | DNLI Denali Therapeutics Inc. | Sale | 17,218 | $16.50 | $284,097 | Direct |
| Jan 3, 2026 | DNLI Denali Therapeutics Inc. | Award | 57,700 | - | $0 | Direct |
| Aug 12, 2025 | DNLI Denali Therapeutics Inc. | Sale | 2,937 | $13.58 | $39,884 | Direct |
| Jan 7, 2025 | DNLI Denali Therapeutics Inc. | Sale | 2,907 | $20.81 | $60,495 | Direct |
| Jan 6, 2025 | DNLI Denali Therapeutics Inc. | Sale | 12,255 | $20.22 | $247,796 | Direct |
| Jan 3, 2025 | DNLI Denali Therapeutics Inc. | Award | 54,180 | - | $0 | Direct |
| Dec 27, 2024 | DNLI Denali Therapeutics Inc. | Exercise | 6,708 | $5.28 | $35,418 | Direct |
| Nov 22, 2024 | DNLI Denali Therapeutics Inc. | Exercise | 20,516 | $0.68 | $13,951 | Direct |
1-10 of 14 transactions